Simmunome AI

About:

Simmunome is an artificial intelligence-based contract research organization.

Website: http://www.simmunome.com

Top Investors: Plug and Play, Next AI, BKR Capital, NEXT Canada, ACET Capital

Description:

Simmunome is an artificial intelligence-based contract research organization. They develop industry-ready computational models of pathogenesis and immunogenesis of various diseases with a particular focus on oncology and the nervous system. Our models are achieved by annotating cellular interactions at an in-depth, comprehensive molecular level to attain physiological accuracy